Search research articles
Contact Us
Filters
Showing results (21-30 of 75) with videos related to
Page
of 8
Sort By:
Bulletin Du Cancer
|
August 16, 2017
[The breakthrough of personalized medicine, new hopes and new challenges]
Ronan Flippot, Christophe Massard, Edouard Auclin, et al.
Therapeutic Advances in Medical Oncology
|
January 25, 2021
Next-generation androgen receptor inhibitors in non-metastatic castration-resistant prostate cancer
Pernelle Lavaud, Clément Dumont, Constance Thibault, et al.
Bulletin Du Cancer
|
June 27, 2022
Therapeutic sequencing in the era of first-line immune checkpoint inhibitor combinations, a novel challenge in patients with metastatic clear-cell renal cell carcinoma
Ronan Flippot, Violaine Gorgeu, Marc Pujalte, et al.
International Journal of Cancer
|
February 7, 2026
International analysis of reimbursement rates and clinical benefit of genitourinary cancer drugs across Canada, France, England, Wales, Scotland, Spain, Italy, and Portugal
Jose C Tapia, Javier Gavira, Diana Matthews, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
February 12, 2021
Prognosis of Incidental Brain Metastases in Patients With Advanced Renal Cell Carcinoma
Ritesh R Kotecha, Ronan Flippot, Taylor Nortman, et al.
Investigational New Drugs
|
May 31, 2020
Safety and efficacy of CDX-014, an antibody-drug conjugate directed against T cell immunoglobulin mucin-1 in advanced renal cell carcinoma
Bradley A McGregor, Michael Gordon, Ronan Flippot, et al.
Clinical Genitourinary Cancer
|
February 3, 2026
Clinical Outcomes of Targeted Therapies Following HIF-2α Inhibition in Metastatic Renal Cell Carcinoma: A Real-World Analysis
Patricia Rioja, Macarena Rey-Cárdenas, Jorge Esteban-Villarrubia, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 15, 2025
Induction of tertiary lymphoid structures in tumor microenvironment to improve anti-tumoral immune checkpoint blockade efficacy
Roman Vion, Matthieu Roulleaux-Dugage, Ronan Flippot, et al.
Prostate Cancer and Prostatic Diseases
|
June 19, 2024
The current landscape of stereotactic body radiation therapy for metastatic castration-resistant prostate cancer
Jennifer Le Guevelou, Francesco Cuccia, Ronan Flippot, et al.
Exploration of Targeted Anti-Tumor Therapy
|
October 28, 2024
Blood-based circulating biomarkers for prediction of immune-checkpoint inhibitors efficacy in renal cell carcinoma
Loubna Omri, Marie Naigeon, Ronan Flippot, et al.
Page
of 8
Search research articles
Search
Showing results (21-30 of 75) with videos related to
Sort By:
Page
of 8
Bulletin Du Cancer
|
August 16, 2017
[The breakthrough of personalized medicine, new hopes and new challenges]
Ronan Flippot, Christophe Massard, Edouard Auclin, et al.
Therapeutic Advances in Medical Oncology
|
January 25, 2021
Next-generation androgen receptor inhibitors in non-metastatic castration-resistant prostate cancer
Pernelle Lavaud, Clément Dumont, Constance Thibault, et al.
Bulletin Du Cancer
|
June 27, 2022
Therapeutic sequencing in the era of first-line immune checkpoint inhibitor combinations, a novel challenge in patients with metastatic clear-cell renal cell carcinoma
Ronan Flippot, Violaine Gorgeu, Marc Pujalte, et al.
International Journal of Cancer
|
February 7, 2026
International analysis of reimbursement rates and clinical benefit of genitourinary cancer drugs across Canada, France, England, Wales, Scotland, Spain, Italy, and Portugal
Jose C Tapia, Javier Gavira, Diana Matthews, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
February 12, 2021
Prognosis of Incidental Brain Metastases in Patients With Advanced Renal Cell Carcinoma
Ritesh R Kotecha, Ronan Flippot, Taylor Nortman, et al.
Investigational New Drugs
|
May 31, 2020
Safety and efficacy of CDX-014, an antibody-drug conjugate directed against T cell immunoglobulin mucin-1 in advanced renal cell carcinoma
Bradley A McGregor, Michael Gordon, Ronan Flippot, et al.
Clinical Genitourinary Cancer
|
February 3, 2026
Clinical Outcomes of Targeted Therapies Following HIF-2α Inhibition in Metastatic Renal Cell Carcinoma: A Real-World Analysis
Patricia Rioja, Macarena Rey-Cárdenas, Jorge Esteban-Villarrubia, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 15, 2025
Induction of tertiary lymphoid structures in tumor microenvironment to improve anti-tumoral immune checkpoint blockade efficacy
Roman Vion, Matthieu Roulleaux-Dugage, Ronan Flippot, et al.
Prostate Cancer and Prostatic Diseases
|
June 19, 2024
The current landscape of stereotactic body radiation therapy for metastatic castration-resistant prostate cancer
Jennifer Le Guevelou, Francesco Cuccia, Ronan Flippot, et al.
Exploration of Targeted Anti-Tumor Therapy
|
October 28, 2024
Blood-based circulating biomarkers for prediction of immune-checkpoint inhibitors efficacy in renal cell carcinoma
Loubna Omri, Marie Naigeon, Ronan Flippot, et al.
Page
of 8